|
1
|
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination.
|
Proc Natl Acad Sci U S A
|
2010
|
1.84
|
|
2
|
Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities.
|
Blood
|
2012
|
1.23
|
|
3
|
Dendritic cell-based cancer gene therapy.
|
Hum Gene Ther
|
2009
|
1.02
|
|
4
|
CD56 marks human dendritic cell subsets with cytotoxic potential.
|
Oncoimmunology
|
2013
|
0.93
|
|
5
|
mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
|
AIDS
|
2012
|
0.88
|
|
6
|
Dysphagia lusoria.
|
CMAJ
|
2009
|
0.88
|
|
7
|
Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC.
|
PLoS One
|
2011
|
0.87
|
|
8
|
Design of an Optimized Wilms' Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In Vivo.
|
Mol Ther Nucleic Acids
|
2013
|
0.86
|
|
9
|
Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.
|
Cancer Immunol Immunother
|
2015
|
0.85
|
|
10
|
Induction of complete remission of acute myeloid leukaemia by pegylated interferon-alpha-2a in a patient with transformed primary myelofibrosis.
|
Br J Haematol
|
2009
|
0.82
|
|
11
|
Interferon α may be back on track to treat acute myeloid leukemia.
|
Oncoimmunology
|
2013
|
0.79
|
|
12
|
Rigler triad in gallstone ileus.
|
CMAJ
|
2013
|
0.79
|
|
13
|
HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells.
|
J Cell Mol Med
|
2014
|
0.77
|
|
14
|
Induction of cytomegalovirus-specific T cell responses in healthy volunteers and allogeneic stem cell recipients using vaccination with messenger RNA-transfected dendritic cells.
|
Transplantation
|
2015
|
0.75
|
|
15
|
Monoclonal gammopathy of undetermined significance.
|
CMAJ
|
2013
|
0.75
|